hepatomegaly/gojaznost

Veza se sprema u međuspremnik

Odaberite vrstu sortiranja

6 rezultati

Prevalence of Hepatomegaly in Children and Adolescents With Type 1 Diabetes Mellitus

Samo registrirani korisnici mogu prevoditi članke

Prijavite se / prijavite se

Type 1 diabetes is a disorder of glucose metabolism that results from insulin deficiency secondary to autoimmune destruction of insulin-secreting β-cells. The prevalence of liver disease among diabetics is estimated to be between 17% and 100%(1). Most of these data were obtained from studies of

Preoperative Omega-3 Polyunsaturated Fatty Acids in Morbidly Obese to Reduce Liver Volume and Steatosis

Samo registrirani korisnici mogu prevoditi članke

Prijavite se / prijavite se

National Lysosomal Acid Lipase Deficiency Study

Samo registrirani korisnici mogu prevoditi članke

Prijavite se / prijavite se

Patients of 3 months to 18 years of age at the time of enrolment who have unexplained transaminase elevation (serum alanine aminotransferase (ALT) levels > 1.5 times the upper limit of normal) for more than 3 months and/or unexplained hepatomegaly or hepatosplenomegaly and/or obesity- unrelated

Effect of Mediterranean Diet on Non-alcoholic Fatty Liver Disease

Samo registrirani korisnici mogu prevoditi članke

Prijavite se / prijavite se

The majority of NAFLD patients are characterized by high body mass index, insulin resistance and they show a remarkably higher energy intake in comparison to individuals without hepatic steatosis. Several authors have proposed dietary weight loss strategies to ameliorate or reverse fatty liver

Novel Association of Cholesterol Ester Storage Disease Due to Lysosomal Acid Lipase Deficiency and Non-Alcoholic Fatty Liver Disease: A Prospective Clinical Study

Samo registrirani korisnici mogu prevoditi članke

Prijavite se / prijavite se

Echocardiography Management for Patients Requiring Care for Non-Cardiac Surgery

Samo registrirani korisnici mogu prevoditi članke

Prijavite se / prijavite se

Step 1: Patient selection The first step in the EGHEM/EGAM process is appropriate patient selection. Patients who have any of the following cardiovascular risk factors and/or comorbidities and are scheduled for a non-cardiac surgery are candidates for EGHEM/EGAM: 1. Urology/gynecology/General

Pridružite se našoj
facebook stranici

Herbal & Natural Medicine

Najkompletnija baza ljekovitog bilja potpomognuta naukom

Radi na 55 jezika
Biljni lijekovi potpomognuti naukom
Prepoznavanje biljaka po slici
Interaktivna GPS karta - označite bilje na lokaciji (uskoro)
Pročitajte naučne publikacije povezane sa vašom pretragom
Pretražite ljekovito bilje po učincima
Organizirajte svoja interesovanja i budite u toku sa istraživanjem vijesti, kliničkim ispitivanjima i patentima

Upišite simptom ili bolest i pročitajte o biljkama koje bi mogle pomoći, unesite travu i pogledajte bolesti i simptome protiv kojih se koristi.
* Sve informacije temelje se na objavljenim naučnim istraživanjima